Science
Immune Continuum
Immunoglobulin E (IgE) in Allergic Conditions
Ozureprubart
Clinical Trials
GSK has acquired RAPT Therapeutics
Further information can be found in the latest press release.
READ MORE
GSK enters agreement to acquire RAPT Therapeutics
January 20, 2026
« back to news page
You are leaving RAPT.com to go to the eczema clinical trial study site.
